Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)
Clinical trial NCT00492284 · COMPLETED
Trial details
- NCT number
- NCT00492284
- Sponsor
- QLT Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2009-05-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.